Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity - PubMed (original) (raw)
Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity
M Falguera et al. Arch Intern Med. 2001 Aug.
Abstract
Background: Community-acquired pneumonia frequently constitutes a nonsevere infection manageable at home. However, for these low-risk episodes, the epidemiological features have not been carefully analyzed.
Objectives: To determine the cause of nonsevere community-acquired pneumonia and to investigate if a correlation exists between cause and severity or comorbidity.
Methods: During a 3-year period, all patients with nonsevere community-acquired pneumonia, according to the Pneumonia Patient Outcome Research Team prognostic classification (patients in groups 1-3), were included in the study. Causes were investigated through the following procedures: cultures of blood, sputum, and pleural fluid; serologic tests; and polymerase chain reaction methods to detect Streptococcus pneumoniae DNA in whole blood or Mycoplasma pneumoniae and Chlamydia pneumoniae DNA in throat swab specimens.
Results: Of 317 initially included patients, 247 were eligible for the study. A microbial diagnosis was obtained in 162 patients (66%), and the main pathogens detected were S pneumoniae (69 patients [28%]), M pneumoniae (40 patients [16%]), and C pneumoniae (28 patients [11%]). For the 58 patients in prognostic group 1, M pneumoniae was the most prevalent cause, and atypical microorganisms constituted 40 (69%) of the isolated agents. In contrast, for patients in prognostic groups 2 and 3, S pneumoniae was the leading agent, and a significant reduction of M pneumoniae cases and a greater presence of other more uncommon pathogens were observed. The existence of comorbid conditions was not a determining factor for particular causes.
Conclusions: Among low-risk patients with community-acquired pneumonia, there was a certain correlation between severity and cause. In contrast, the existence of a comorbidity did not have a predictive causative value.
Similar articles
- Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
Lochindarat S, Suwanjutha S, Prapphal N, Chantarojanasiri T, Bunnag T, Deerojanawong J, Kunakorn M, Srisan P. Lochindarat S, et al. Int J Tuberc Lung Dis. 2007 Jul;11(7):814-9. Int J Tuberc Lung Dis. 2007. PMID: 17609060 - Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia.
Liu G, Talkington DF, Fields BS, Levine OS, Yang Y, Tondella ML. Liu G, et al. Diagn Microbiol Infect Dis. 2005 May;52(1):7-14. doi: 10.1016/j.diagmicrobio.2005.01.005. Diagn Microbiol Infect Dis. 2005. PMID: 15878436 - Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G, Ip M, Lee N, Rainer TH, Man SY, Cockram CS, Antonio GE, Ng MH, Chan MH, Chau SS, Mak P, Chan PK, Ahuja AT, Sung JJ, Hui DS. Lui G, et al. Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5. Respirology. 2009. PMID: 19818051 - The role of atypical pathogens in community-acquired pneumonia.
Gupta SK, Sarosi GA. Gupta SK, et al. Med Clin North Am. 2001 Nov;85(6):1349-65, vii. doi: 10.1016/s0025-7125(05)70384-9. Med Clin North Am. 2001. PMID: 11680106 Review.
Cited by
- Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.
Navarro-Torné A, Montuori EA, Kossyvaki V, Méndez C. Navarro-Torné A, et al. Hum Vaccin Immunother. 2021 Oct 3;17(10):3670-3686. doi: 10.1080/21645515.2021.1923348. Epub 2021 Jun 9. Hum Vaccin Immunother. 2021. PMID: 34106040 Free PMC article. - Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.
Hogerwerf L, DE Gier B, Baan B, VAN DER Hoek W. Hogerwerf L, et al. Epidemiol Infect. 2017 Nov;145(15):3096-3105. doi: 10.1017/S0950268817002060. Epub 2017 Sep 26. Epidemiol Infect. 2017. PMID: 28946931 Free PMC article. Review. - Review of nemonoxacin with special focus on clinical development.
Qin X, Huang H. Qin X, et al. Drug Des Devel Ther. 2014 Jul 5;8:765-74. doi: 10.2147/DDDT.S63581. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25045247 Free PMC article. Review. - Clinical characteristics of Q fever and etiology of community-acquired pneumonia in a tropical region of southern Taiwan: a prospective observational study.
Lai CH, Chang LL, Lin JN, Chen WF, Wei YF, Chiu CT, Wu JT, Hsu CK, Chen JY, Lee HS, Lin HH, Chen YH. Lai CH, et al. PLoS One. 2014 Jul 17;9(7):e102808. doi: 10.1371/journal.pone.0102808. eCollection 2014. PLoS One. 2014. PMID: 25033402 Free PMC article. - Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumonia.
Liu HH. Liu HH. Curr Ther Res Clin Exp. 2004 May;65(3):225-38. doi: 10.1016/S0011-393X(04)80047-X. Curr Ther Res Clin Exp. 2004. PMID: 24764589 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources